Long-term Safety and Efficacy of a Sustained-Release Bimatoprost Ocular Ring

Ophthalmology. 2017 Oct;124(10):1565-1566. doi: 10.1016/j.ophtha.2017.04.022. Epub 2017 May 17.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antihypertensive Agents / administration & dosage*
  • Antihypertensive Agents / adverse effects
  • Bimatoprost / administration & dosage*
  • Bimatoprost / adverse effects
  • Delayed-Action Preparations
  • Double-Blind Method
  • Drug Implants / adverse effects
  • Drug Implants / therapeutic use*
  • Female
  • Glaucoma / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Ocular Hypertension / drug therapy*

Substances

  • Antihypertensive Agents
  • Delayed-Action Preparations
  • Drug Implants
  • Bimatoprost

Associated data

  • ClinicalTrials.gov/NCT02143843